India, July 15 -- Cannara Biotech Inc. (LOVE.TO), a premium-grade cannabis producer, on Wednesday reported 16.5 percent growth in third quarter revenue, compared to the prior year.
Company Profile
Cannara Biotech Inc. is a commercial-stage, vertically integrated cannabis company that cultivates, processes, and markets premium cannabis products for the Canadian recreational and medical markets.
The company operates large-scale indoor cultivation facilities in Quebec and sells cannabis flower, pre-rolls, vapes, concentrates, and Cannabidiol products under brands including Tribal, Nugz, and Orchid CBD.
Third Quarter 2026 Financial Highlights
In the third quarter of 2026, total net revenue increased by 16.5% or C$4.5 million to C$31.83 mil...